Bioseek Share Discussion Threads

[tpaulbeaumont] 27/2/2012 07:35

arent all 3 of you calling au lower? :)
ewi will just keep moving their 'b' until it starts going up or cant possibly be a 'b' ;)

[joe moon] 27/2/2012 07:23

BATTLE ON !

AT VERSES EW



Ill go for 580 low but dont have a time stamp

[and then] 27/2/2012 07:20

Its funny how it works isn't it?! I have us coming down to 10620 area before breaking out north to form a fresh 1&2 of a fifth...

[joe moon] 27/2/2012 07:15

ewi making the classic trading mistake of sticking to their belief and trying to justify it ,,,stop should have been at 702 JOE MOON

Feb 26 2012 9:21PM ET: The dip beneath 1.0661 weakens the immediacy of the bullish stance but doesn't change the big picture call for strength, just delays it. At the moment, price is correcting lower in wave 'b' and until we spot an initial five wave rise above 1.0720 we will be patient in watching for a five wave rise in wave 'c.' -- MG

Feb 26 2012 5:54PM ET: Continue to favor a rise in Aussie following a corrective decline that we would like to see find support above 1.0661. Ideally, the low at 1.0683 will hold until we spot a minute five wave rise to boost the call for a rise. -- Matthew Gress

Feb 24 2012 1:12PM ET: The setback from 1.0757 looks corrective and barring a breach of 1.0661 we can look forward to an accelerating advance in AUDUSD. -- JM

Feb 24 2012 11:28 AM ET: There's been little change, certainly not enough to question the outlook for further AUDUSD gains. A breakout above 1.0750 would bolster the already bullish outlook. -- JM

Feb 24 2012 9:23 AM ET: The short-term picture has been discussed and there is little change. Backing out a bit the daily chart reveals a thrust from a triangle that should carry to new highs. This pattern leads me to believe setback, as corrections, will unfold in three waves and rallies will prove impulsive. The setback from 1.0847 abides by those expectations. It's clearly a corrective setback, in three waves with wave c (circle) within two pips of equaling wave a (circle). AUDUSD is headed toward 1.0847, at least, and barring a break of 1.0598 the bullish view will stand. -- Jim Martens

[and then] 27/2/2012 06:50

Probably no coincidence that the high and low from last night/this morning has created a set of parallel lines for a channel;

[and then] 26/2/2012 18:50

Now this will be a nice straight forward trade if it shapes up; potential 3push on the Spain35, its been very very easy to read recently, so lets hope it continues...

[and then] 26/2/2012 13:26

Look at the evidence! Once again the 4hr 200ma is deadly. Combine it with a 123 and it was a buy all the way;





Yes, ok i know; you want me to flag things before they happen! The point of the above is to look at it like a jigsaw puzzle. During the decline last week, i was expecting it to negate the previous 1&2, therefore price needed to reverse in the small envelope shown as the bottom two lines on the 4hr chart. Once it did we look out for more evidence. Sure you could place a trade there and then, but that's not the way i trade. The point is that we need to build a picture and then together once the evidence is in place, look for a set-up to trade it for a minimal risk. The trade was on the 15min once the 123 was triggered. After this you can increase the stake to max 3% risk once the last LH was breached together with the pullback and break-out...

[joe moon] 26/2/2012 13:25

agreed there at

[and then] 26/2/2012 13:10

6600 coming soon to a screen near you...

[nesty1760] 25/2/2012 14:09

Buywell2 - Well I think we will have to hear something soon. Be pushing into mid March soon.

[buywell2] 24/2/2012 15:32

Yes the finals are due in a few weeks

[nesty1760] 23/2/2012 23:40

Hopefully will hear some news soon.

[restart09] 23/2/2012 18:52

thanks AT for your thoughts on aud i have the same view on 4 but one difference is i dont think it finish yet or will finish any time soon. If 3 lasted 2 months and we have a flat 4 it will not finish in a few days. On a larger timeframe if we take the rise from 0.9385 to 1.0752 as A or 1 then the fall to 0.9675 is B or 2 and the size is near perfect to 0.764. So C or 3 the rise from 0.9661 has already been bigger that 0.618 and 0.764 of A therefore min should be A=C with target at 1.1027 +-50 pips for margin of error

[nesty1760] 23/2/2012 14:56

I have spoken to Asterand. I got the word 'ongoing' and the process is taking place and so far they are trying to keep to the orginal timescales and shareholders will be informed when the process has finshed.

Sounds like to me there could be a few offers to wade through?

[spaceparallax] 23/2/2012 14:06

Sadly, no one values your opinion

[buywell2] 23/2/2012 13:45

Turning things around ... I don´t think so


This was the last outlook published by Asterand in 2011

Outlook

On July 29th, as part of a Board Changes announcement, we indicated confidence in achieving market expectations for the year as a whole. Since then, we have experienced lower than anticipated sales in the Tissue Based Solutions business (excluding BioSeek) causing us to lower our tissue sales outlook for the remainder of the year. As a consequence, we now believe that revenue and earnings for the year will be materially lower than current market expectations. We expect to experience a slight retraction in the Tissue Based Solutions business (excluding BioSeek) for the full year as compared to 2010. We believe that the retraction is driven by inefficiency in our ability to supply an increasing demand for highly annotated materials (something that we are addressing). Conversely, the BioSeek business continues to grow at a rate of approximately 50% as compared to last year. Thus Group revenue for 2011, while materially lower than market expectations, is expected to still be greater than 2010.

Operating costs continue to be managed carefully, although we are anticipating exceptional costs in H2 surrounding Board changes. In addition exceptional interest charges are anticipated in relation to the BioSeek debt. Additionally, the Group has taken on a total of $9.3 million in debt to finance the BioSeek acquisition with corresponding debt service obligations.

The post period payment to the former BioSeek shareholders of $2.5 million, plus accrued interest, has significantly decreased our cash position. In addition, worse than expected trading post period end will result in a breach of banking covenants in August and the re-classification of the $2.7 million term loan as current debt. Additional funds must be raised in the near future to see the Group through this volatile trading period. Based on discussions with potential investors, the Board believes that it has a reasonable expectation that sufficient funds will be raised within an appropriate timeframe to continue operating as a going concern and provide enough working capital headroom to fund improved tissue sourcing strategies, which are expected to improve supply and thereby stabilise the non-BioSeek sales.

In addition to the inherent risk that funds cannot be raised within the necessary timeframe, the following are considered to be additional uncertainties related to raising these funds:

-- Shareholder approval - raising sufficient funds in a cost efficient manner is predicated on shareholder approval. The Board intends to convene a General Meeting at which the necessary resolutions will be put to shareholders. While there is uncertainty over the outcome of these votes, the Board has a reasonable expectation that approval to proceed with this strategy will be forthcoming.

-- Loan covenants - it will be necessary to re-negotiate the conditions attached to the Group's banking facility. It is likely that such re-negotiation will be linked to the raising of capital as above. While there is a risk that the Group will not be able to successfully renegotiate the covenants with its providers of finance, the Board has a reasonable expectation based on discussions with the Group's lenders that facilities will continue to be made available.

-- Trading results - management have prepared revised budgets and projections which they believe are prudent and achievable, taking into account the volatility in sales (excluding BioSeek) currently being experienced. However, the achievement of these trading results is uncertain.

The directors have concluded that the combination of these circumstances represents a material uncertainty that casts significant doubt upon the Group's ability to continue as a going concern and that, therefore, the Group may be unable to realise its assets and discharge its liabilities in the normal course of business. Nevertheless, after considering the uncertainties described above and making appropriate enquiries, the directors have a reasonable expectation that the company will obtain adequate resources to continue in operational existence for the foreseeable future. For these reasons, they continue to adopt the going concern basis of accounting in preparing the interim financial statements.



So ....................

The next results should make very bad reading

Which is why the company is trying to get itself sold

Bioseek only won another order from the EPA in the USA for testing 100 compounds , worth less than $700k

That this news should then put on over 2p on the price ie $3m does not compute

Bioseek owners are owed circa $9m by Asterand equivalent to 4.5p a share
´´Additionally, the Group has taken on a total of $9.3 million in debt to finance the BioSeek acquisition with corresponding debt service obligations. ´´

With interest payments this has now probably reached circa $10m


Then after that outlook, this was published

The $25 million contract with the US government has just been cancelled at the one-year mark. Even worse, the company will have trouble recovering some of its first-year costs. What a mess they are in.

Asterand plc ("Asterand" or the "Group" - LSE: ATD) announces today that it has received notification from the National Cancer Institute ("NCI") that NCI will not exercise extension options with its suppliers on The Cancer Genome Atlas contract ("TCGA") as appropriate funds are not available. Therefore, the contract with Asterand is due to expire on 23 February 2012. The Company was also notified that it may apply to the NCI for a no cost contract extension to realise any unexpended funds beyond this expiration date.

In the announcement issued on 1 October 2010, the Company had stated that the TCGA project was worth up to $5.4m over 17 months, with an option to extend for up to $24.3m, over a five year term. As was mentioned in the Interim Results, Asterand has experienced inefficiencies in supplying against an increasing demand for highly annotated tissues. This situation is being addressed but may affect the Company's ability to realise the full $5.4 million by February 2012. Therefore, the Company has applied for an extension of the current contract to allow expenditures beyond February 2012. Although the Company remains optimistic that an extension will be granted, this is not guaranteed.

Expected revenue for the TCGA through 2011 remains consistent with the guidance provided in the Company's Interim Results issued 31 August 2011. As such, the Company does not expect any impact on the projections for the current financial year as a consequence of this notification.

Following on from the statements made in Asterand's Interims Results announcement on 31 August, the Company confirms that there has been no further deterioration in trading and that it will provide shareholders with an update in the next few weeks. As also stated in the recent interims, Asterandis in discussions with a number of parties with a view to raising additional capital and expects to make a further announcement in due course.


So ..........

We are where we are with the company having to sell itself because it can´t continue

I posted several months ago a calculation showing the net worth was around 2.5p

Note the chart went to that months later ....... I have seen no reason to believe things are any different now

dyor

[joe moon] 23/2/2012 13:15

yeh im keeping a check on them to see how they do

[and then] 23/2/2012 12:50

Lol, no mate. That's nice of them... ;)

[joe moon] 23/2/2012 12:25

yeh you seen they are doing a free week?

[and then] 23/2/2012 12:09

I would say, they're not far out! Looking for 1.0748 before a pullback to create a flagline from the peak. It can be waves 1&2 at that stage, before breaking this powerfully in wave 3... It may have reached wave 1 peak already, but other factors make me think not. Pullback at mo looks like triggering 30/40 points higher in the next hour...

[joe moon] 23/2/2012 11:43

[Higher]
Key Levels: 1.0598




Focus is on price rising in five waves from 1.0598 to above 1.0818. Interim support if needed is currently embedded around 1.0657. Price printing above the 1.0734 area will next bolster this view. -- Al

Feb 23 2012 3:05 AM ET: Focus is on price rising in five waves from 1.0598 to above 1.0818. Interim support if needed is currently embedded around 1.0632. Price printing above 1.0687 will next bolster this view. -- Al Graham

Feb 23 2012 12:20 AM ET: Aussie found support near the 1.0600 level where wave 'A' equals wave 'C' and if it continues to do so while rising above initial resistance at 1.0659 in five waves a bottom would come into focus. -- MG

Feb 22 2012 6:17PM ET: As Jim mentioned, the rise from 1.0605 was not in a clear five waves and price is now ticking beneath 1.0619 which cautions the immediate call for a bottom. Even if price ticks beneath 1.0605 we will continue to look for an initial five wave rise that will boost the call for news highs above 1.0801 in wave '5.' -- Matthew Gress

[e-mail] -- Customer Support
Currency Q&A Forum (Beta) -- Analyst Questions

[and then] 22/2/2012 14:24

and then - 22 Feb'12 - 07:27 - 1061 of 1064 edit

'There a secondary TP for the EA around 12462,...'

--------------------------

Well that's that one hit too. Will be interesting to see if its reverse from here...

[and then] 22/2/2012 12:07

An interesting point right now on the FTSE;

Here is a perfect and easily identifiable 3push on cable, finishing with a 123 and break out of the top TL.



Next, the FTSE; could easily be our 3 push down before a reversal, however, its also doing my fave... a breach of the last significant HL (the last before the latest highest print), which should lead to a pullback and drop.

Not a lot of use unless you know what the confirmation trigger is, however, you can watch for a break of either TL;

[joe moon] 22/2/2012 11:40

audi will go to approx 500 i recon b4 it bottoms